Ieq Capital, LLC Glycomimetics Inc Transaction History
Ieq Capital, LLC
- $10.1 Billion
- Q4 2024
A detailed history of Ieq Capital, LLC transactions in Glycomimetics Inc stock. As of the latest transaction made, Ieq Capital, LLC holds 38,363 shares of GLYC stock, worth $9,974. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,363
Previous 38,363
-0.0%
Holding current value
$9,974
Previous $6,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GLYC
# of Institutions
35Shares Held
17.2MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA9.54MShares$2.48 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$694,2540.0% of portfolio
-
Siren, L.L.C. New York, NY1.97MShares$510,9290.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny781KShares$203,0860.0% of portfolio
-
Black Rock Inc. New York, NY723KShares$188,0270.0% of portfolio
About GLYCOMIMETICS INC
- Ticker GLYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,423,900
- Market Cap $13.6M
- Description
- GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...